Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03446833 · ClinicalTrials.gov registry record · NA
LFP Beta aDBS Feasibility Study
A NA study, sponsored by MedtronicNeuro.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03446833 is a NA study that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 1 participants.
The verdict
NCT03446833, a NA study, was terminated before completion, sponsored by MedtronicNeuro.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to use local field potentials as control signals for adjusting DBS stimulation settings under varying patient states and to assess patient outcomes.
Interventions
- DEVICE The LFP Beta aDBS System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2019-02-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03446833
The ClinicalTrials.gov registry entry for NCT03446833 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The LFP Beta aDBS System is the first listed.
NCT03446833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03446833 about?
NCT03446833 is a clinical study titled "LFP Beta aDBS Feasibility Study". The purpose of this study is to use local field potentials as control signals for adjusting DBS stimulation settings under varying patient states and to assess patient outcomes.
What is the current status of trial NCT03446833?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2018-09-04. Estimated completion is 2019-02-06.
What interventions are being tested in trial NCT03446833?
The interventions under investigation include: The LFP Beta aDBS System (DEVICE).
Who is sponsoring clinical trial NCT03446833?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.